Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Claire R. Morden"'
Autor:
Mark W. Nachtigal, Claire R. Morden, Zelda Lichtensztejn, Kirk J. McManus, Ally C. Farrell, Alon D. Altman, Mirka Sliwowski
Publikováno v:
Gynecologic Oncology. 161:769-778
Objective High-grade serous ovarian cancer (HGSOC) is the most lethal gynaecological malignancy in women with a high level of mortality, metastatic disease, disease recurrence and multi-drug resistance. Many previous studies have focused on character
Autor:
Karolin Heinze, Martin Hölzer, Martin Ungelenk, Melanie Gerth, Jürgen Thomale, Regine Heller, Claire R. Morden, Kirk J. McManus, Alexander S. Mosig, Matthias Dürst, Ingo B. Runnebaum, Norman Häfner
Publikováno v:
Cancers
Volume 13
Issue 3
Cancers, Vol 13, Iss 476, p 476 (2021)
Volume 13
Issue 3
Cancers, Vol 13, Iss 476, p 476 (2021)
The prognosis of late-stage epithelial ovarian cancer (EOC) patients is affected by chemotherapy response and the malignant potential of the tumor cells. In earlier work, we identified hypermethylation of the runt-related transcription factor 3 gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ddf5868565a6f34679ea011d3a93abef
https://www.ncbi.nlm.nih.gov/pubmed/33530588
https://www.ncbi.nlm.nih.gov/pubmed/33530588
Autor:
Mark W. Nachtigal, Claire R. Morden, Ally C. Farrell, Kirk J. McManus, Mirka Sliwowski, Zelda Lichtensztejn
Publikováno v:
Clinical Cancer Research. 26:A20-A20
High-grade serous ovarian cancer (HGSOC) is the most aggressive epithelial ovarian cancer subtype, and >75% of patients experience tumor recurrence following initial treatment, often with drug-resistant disease. Unfortunately, the aberrant events dri